Neogen Surges 102.8% in a Year: What's Driving the Rally?
NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.
Zacks Investment Research8/31/2026Positive
NEOG
Neogen CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.58B
P/E Ratio
—
EPS
$-0.04
Beta
1.76
52W High
$12.85
52W Low
$4.90
50-Day MA
$10.72
200-Day MA
$9.36
Dividend Yield
—
Profit Margin
-0.91%
Forward P/E
16.00
PEG Ratio
0.66
About Neogen Corporation
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
Fundamentals
| Revenue (TTM) | $870.40M |
| Gross Profit (TTM) | $408.50M |
| EBITDA | $94.70M |
| Operating Margin | 1.38% |
| Return on Equity | -0.38% |
| Return on Assets | -0.40% |
| Revenue/Share (TTM) | $4.00 |
| Book Value | $9.61 |
| Price-to-Book | 1.21 |
| Price-to-Sales (TTM) | 2.96 |
| EV/Revenue | 3.618 |
| EV/EBITDA | 18.47 |
| Quarterly Earnings Growth (YoY) | -85.60% |
| Quarterly Revenue Growth (YoY) | -0.10% |
| Shares Outstanding | $218.11M |
| Float | $217.10M |
| % Insiders | 0.70% |
| % Institutions | 111.48% |
Historical Volatility
HV 10-Day
22.29%
HV 20-Day
32.22%
HV 30-Day
67.39%
HV 60-Day
56.05%
HV Rank
66.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($13.33 target)
1
Strong Buy1
Buy2
HoldLatest News
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
Zacks Investment Research8/26/2026Positive
Neogen (NEOG) is a Great Momentum Stock: Should You Buy?
Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research8/24/2026Positive
Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock
Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks Investment Research8/11/2026Positive
PRGO vs. NEOG: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research8/10/2026Positive
Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript
Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript
Seeking Alpha7/30/2026Neutral
Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research7/30/2026Positive
Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates
Neogen (NEOG) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.
Zacks Investment Research7/30/2026Positive
Neogen Q4 Earnings Call Highlights
Neogen NASDAQ: NEOG reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined increased spending on research and development, commercial capabilities and technology.
MarketBeat7/30/2026Positive
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2026 and provided financial guidance for its fiscal year first quarter and full fiscal year 2027. “We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way we approach customers and our core markets. Fiscal ye.
Business Wire7/30/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NEOG and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026